Our formulation facility at Dahej was inspected by US FDA from July 23-27, 2018. At the end of the inspection, no Form 483 was issued to us...

The warning letter was issued on Monday for Pithampur unit II of Indore and its Goa plant.

In a BSE filing, Ajanta Pharma said it has recieved "final approval for Entacapone tablets from US FDA. It is a bioequivalent generic versi...

Form 483 is issued to a company's management after completion of inspection of its facility to notify regarding objectionable conditions.

There has been media reports saying the company has got import alert from US FDA for its Paithan unit at Aurangabad.

Ajanta Pharma was trading 4.35 per cent lower at Rs 1,706 in early trade around 10.30 am (IST) on BSE.

Ajanta Pharma's Amlodipine + Olmesartan Medoxomil tablets are a generic version of Daiichi Sankyo Inc's Azor tablets

The approval from the United States Food and Drug Administration (USFDA) is for the capsules in the strengths of 20mg/1100 mg and 40 mg/110...

Interestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...

The company has launched the drug in two strengths of 5 mg and 10 mg tablets to address different level of treatment after the approval fro...

The US Food and Drug Administration has so far granted final approvals for 10 abbreviated new drug applications and 2 tentative approvals.

Ajanta Pharma has received final approval for its generic version of acute migraine pain relief drug Zolmitriptan tablets from the US healt...

The stock went up 3.69 per cent to Rs 1,448.80 on BSE.

The approval is for multiple strengths of 6.25mg and 12.5mg of the generic version of Janssen Pharmaceuticals' Axert tablets, Ajanta Pharma...

Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American marke...

Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market.

Drug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules.